🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Friedreich Ataxia

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia NCT06692296NA1 site📍 Pieve di Soligo IRCCS Eugenio Medea · Tests: Balance training over stabilometric platform, Balance training by means of conventional rehabilitation Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia NCT05302271Phase 11 site📍 New York Weill Medical College of Cornell University · Tests: AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN… Clinical Course Of Disease In Participants With FA-CM NCT06865482n/a19 sites📍 La Jolla📍 Tampa📍 Indianapolis Lexeo Therapeutics Friedreich Ataxia Nerve Ultrasund NCT07508631n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Nerve ultrasound - routine exam A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia NCT06874010Phase 1, Phase 23 sites📍 Sydney📍 East Melbourne📍 Melbourne Design Therapeutics, Inc. · Tests: DT-216P2 Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study NCT06016946n/a34 sites📍 Los Angeles📍 Denver📍 Gainesville Friedreich's Ataxia Research Alliance A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia NCT07778836Phase 34 sites📍 Tampa📍 Chicago📍 Eatontown Larimar Therapeutics, Inc. · Tests: Nomlabofusp, Placebo Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA) NCT02316314n/a1 site📍 New York Weill Medical College of Cornell University · Tests: Cardiac magnetic resonance imaging (CMR), Exercise-stress test, Echocardiogram (ECHO), Cardiac-related blood studies An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia NCT06447025Phase 210 sites📍 Los Angeles📍 San Francisco📍 Gainesville Larimar Therapeutics, Inc. · Tests: CTI-1601 A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors NCT06623890n/a14 sites📍 Los Angeles📍 Aurora📍 Gainesville Biogen · Tests: Omaveloxolone Efficacy of Omaveloxolone Treatment for Dysphagia in French Patients With Friedreich's Ataxia NCT07013292n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: SKYCLARYS (omaveloxolone) A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies NCT06628687n/a1 site📍 Morrisville Biogen · Tests: Omaveloxolone Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia NCT05943002n/a6 sites📍 Innsbruck📍 Paris📍 Aachen German Center for Neurodegenerative Diseases (DZNE) Cardiac Output and Fatigue in Friedreich's Ataxia NCT07444333NA1 site📍 New York Scott Barbuto · Tests: Aerobic Exercise Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome. NCT07095062NA1 site📍 Conegliano IRCCS Eugenio Medea · Tests: HD-EEG recordings, combined with cognitive and motor assessment A Study of SGT-212 Gene Therapy in Friedreich's Ataxia NCT07180355Phase 13 sites📍 Los Angeles📍 Columbus📍 Philadelphia Solid Biosciences Inc. · Tests: SGT-212 Biomarkers in Friedreich's Ataxia NCT02497534n/a1 site📍 Gainesville University of Florida Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy NCT07721025Phase 21 site📍 Tampa Lexeo Therapeutics · Tests: LX2006, Usual Care
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy